{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:59:09Z","timestamp":1789167549204,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202215"],"award-info":[{"award-number":["82202215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272041"],"award-info":[{"award-number":["82272041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959119"],"award-info":[{"award-number":["91959119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873903"],"award-info":[{"award-number":["81873903"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001871"],"award-info":[{"award-number":["82001871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302246"],"award-info":[{"award-number":["82302246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB206"],"award-info":[{"award-number":["2022CFB206"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00259-024-07062-5","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:38:10Z","timestamp":1737351490000},"page":"2132-2144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET\/CT after local regional treatment in patients with hepatocellular carcinoma"],"prefix":"10.1007","volume":"52","author":[{"given":"Dongling","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangde","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-8884","authenticated-orcid":false,"given":"Haojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"7062_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4.","journal-title":"Lancet"},{"key":"7062_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1148\/rg.220022","volume":"42","author":"N Horvat","year":"2022","unstructured":"Horvat N, de Oliveira AI, de Clemente Oliveira B, Araujo-Filho JAB, El Homsi M, Elsakka A, et al. Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists. Radiographics. 2022;42:1670\u201389. https:\/\/doi.org\/10.1148\/rg.220022.","journal-title":"Radiographics."},{"key":"7062_CR3","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/gutjnl-2019-318934","volume":"69","author":"M Kudo","year":"2020","unstructured":"Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, et al. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 2020;69:1492\u2013501. https:\/\/doi.org\/10.1136\/gutjnl-2019-318934.","journal-title":"Gut"},{"key":"7062_CR4","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/s00330-019-06623-9","volume":"30","author":"SW Kim","year":"2020","unstructured":"Kim SW, Joo I, Kim HC, Ahn SJ, Kang HJ, Jeon SK, et al. LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features. Eur Radiol. 2020;30:2861\u201370. https:\/\/doi.org\/10.1007\/s00330-019-06623-9.","journal-title":"Eur Radiol"},{"key":"7062_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2463\/mrms.rev.2022-0118","volume":"22","author":"Y Tsujita","year":"2023","unstructured":"Tsujita Y, Sofue K, Ueshima E, Ueno Y, Hori M, Tsurusaki M, et al. Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma. Magn Reson Med Sci. 2023;22:209\u201320. https:\/\/doi.org\/10.2463\/mrms.rev.2022-0118.","journal-title":"Magn Reson Med Sci"},{"key":"7062_CR6","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.4240\/wjgs.v14.i10.1150","volume":"14","author":"X Cao","year":"2022","unstructured":"Cao X, Shi H, Dou WQ, Zhao XY, Zheng YX, Ge YP, et al. Can DKI-MRI predict recurrence and invasion of peritumoral zone of hepatocellular carcinoma after transcatheter arterial chemoembolization? World J Gastrointest Surg. 2022;14:1150\u201360. https:\/\/doi.org\/10.4240\/wjgs.v14.i10.1150.","journal-title":"World J Gastrointest Surg"},{"key":"7062_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00270-020-02487-5","volume":"43","author":"H Moschouris","year":"2020","unstructured":"Moschouris H, Malagari K, Dimakis A, Kiakidis T, Anagnostopoulou A. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography. Cardiovasc Intervent Radiol. 2020;43:1075\u201383. https:\/\/doi.org\/10.1007\/s00270-020-02487-5.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"7062_CR8","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1007\/s00330-020-06923-5","volume":"30","author":"S Mule","year":"2020","unstructured":"Mule S, Chalaye J, Legou F, Tenenhaus A, Calderaro J, Galletto Pregliasco A, et al. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET\/CT. Eur Radiol. 2020;30:5348\u201357. https:\/\/doi.org\/10.1007\/s00330-020-06923-5.","journal-title":"Eur Radiol"},{"key":"7062_CR9","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00259-017-3724-2","volume":"44","author":"S Li","year":"2017","unstructured":"Li S, Peck-Radosavljevic M, Ubl P, Wadsak W, Mitterhauser M, Rainer E, et al. The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab. Eur J Nucl Med Mol Imaging. 2017;44:1732\u201341. https:\/\/doi.org\/10.1007\/s00259-017-3724-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7062_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/lt.22069","volume":"16","author":"YK Kim","year":"2010","unstructured":"Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, et al. Usefulness 18F-FDG positron emission tomography\/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Liver Transpl. 2010;16:767\u201372. https:\/\/doi.org\/10.1002\/lt.22069.","journal-title":"Liver Transpl"},{"key":"7062_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00259-022-06022-1","volume":"50","author":"J Zhang","year":"2023","unstructured":"Zhang J, He Q, Jiang S, Li M, Xue H, Zhang D, et al. [(18)F]FAPI PET\/CT in the evaluation of focal liver lesions with [(18)F]FDG non-avidity. Eur J Nucl Med Mol Imaging. 2023;50:937\u201350. https:\/\/doi.org\/10.1007\/s00259-022-06022-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7062_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40644-023-00626-y","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jiang S, Li M, Xue H, Zhong X, Li S, et al. Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET\/CT in staging and therapeutic management of hepatocellular carcinoma. Cancer Imaging. 2023;23:106. https:\/\/doi.org\/10.1186\/s40644-023-00626-y.","journal-title":"Cancer Imaging"},{"key":"7062_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7150\/thno.69475","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Chen J, Pang Y, Fu K, Shang Q, Wu H, et al. Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review. Theranostics. 2022;12:1557\u201369. https:\/\/doi.org\/10.7150\/thno.69475.","journal-title":"Theranostics"},{"key":"7062_CR14","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.2147\/CMAR.S374916","volume":"14","author":"D Chen","year":"2022","unstructured":"Chen D, Chang C, Zhang Y, Yang S, Wang G, Lin L, et al. Different Features of (18)F-FAPI, (18)F-FDG PET\/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the Literature. Cancer Manag Res. 2022;14:2649\u201355. https:\/\/doi.org\/10.2147\/CMAR.S374916.","journal-title":"Cancer Manag Res"},{"key":"7062_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2967\/jnumed.121.262134","volume":"63","author":"X Jin","year":"2022","unstructured":"Jin X, Wei M, Wang S, Wang G, Lai Y, Shi Y, et al. Detecting Fibroblast Activation Proteins in Lymphoma Using (68)Ga-FAPI PET\/CT. J Nucl Med. 2022;63:212\u20137. https:\/\/doi.org\/10.2967\/jnumed.121.262134.","journal-title":"J Nucl Med"},{"key":"7062_CR16","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.3390\/cancers13174432","volume":"13","author":"YJ Huh","year":"2021","unstructured":"Huh YJ, Kim DH, Kim B, Choi JI, Rha SE. Per-Feature Accuracy of Liver Imaging Reporting and Data System Locoregional Treatment Response Algorithm: A Systematic Review and Meta-Analysis. Cancers (Basel). 2021;13:4432. https:\/\/doi.org\/10.3390\/cancers13174432.","journal-title":"Cancers (Basel)."},{"key":"7062_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jso.27138","volume":"127","author":"SP Madani","year":"2023","unstructured":"Madani SP, Mirza-Aghazadeh-Attari M, Mohseni A, Pawlik T, Kamel IR. Diffuse infiltrative hepatocellular carcinoma: Multimodality imaging manifestations. J Surg Oncol. 2023;127:385\u201393. https:\/\/doi.org\/10.1002\/jso.27138.","journal-title":"J Surg Oncol"},{"key":"7062_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11307-017-1150-2","volume":"20","author":"Z Wang","year":"2018","unstructured":"Wang Z, Kang F, Gao Y, Liu Y, Xu X, Ma X, et al. Metformin Promotes 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Hepatocellular Carcinoma Cells Through FoxO1-Mediated Downregulation of Glucose-6-Phosphatase. Mol Imaging Biol. 2018;20:388\u201397. https:\/\/doi.org\/10.1007\/s11307-017-1150-2.","journal-title":"Mol Imaging Biol"},{"key":"7062_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1148\/radiol.2017161607","volume":"284","author":"R Chen","year":"2017","unstructured":"Chen R, Li J, Zhou X, Liu J, Huang G. Fructose-1,6-Bisphosphatase 1 Reduces (18)F FDG Uptake in Hepatocellular Carcinoma. Radiology. 2017;284:844\u201353. https:\/\/doi.org\/10.1148\/radiol.2017161607.","journal-title":"Radiology"},{"key":"7062_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.crad.2014.09.020","volume":"70","author":"HJ Song","year":"2015","unstructured":"Song HJ, Cheng JY, Hu SL, Zhang GY, Fu Y, Zhang YJ. Value of 18F-FDG PET\/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE. Clin Radiol. 2015;70:128\u201337. https:\/\/doi.org\/10.1016\/j.crad.2014.09.020.","journal-title":"Clin Radiol"},{"key":"7062_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/1751-2980.12064","volume":"14","author":"XY Wang","year":"2013","unstructured":"Wang XY, Chen D, Zhang XS, Chen ZF, Hu AB. Value of (1)(8)F-FDG-PET\/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound. J Dig Dis. 2013;14:433\u20138. https:\/\/doi.org\/10.1111\/1751-2980.12064.","journal-title":"J Dig Dis"},{"key":"7062_CR22","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.2967\/jnumed.110.079244","volume":"51","author":"HO Kim","year":"2010","unstructured":"Kim HO, Kim JS, Shin YM, Ryu JS, Lee YS, Lee SG. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET\/CT. J Nucl Med. 2010;51:1849\u201356. https:\/\/doi.org\/10.2967\/jnumed.110.079244.","journal-title":"J Nucl Med"},{"key":"7062_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s13139-012-0138-8","volume":"46","author":"SH Kim","year":"2012","unstructured":"Kim SH, Won KS, Choi BW, Jo I, Zeon SK, Chung WJ, et al. Usefulness of F-18 FDG PET\/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular Carcinoma. Nucl Med Mol Imaging. 2012;46:102\u201310. https:\/\/doi.org\/10.1007\/s13139-012-0138-8.","journal-title":"Nucl Med Mol Imaging"},{"key":"7062_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.14701\/ahbps.2017.21.4.194","volume":"21","author":"KJ Cho","year":"2017","unstructured":"Cho KJ, Choi NK, Shin MH, Chong AR. Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection. Ann Hepatobiliary Pancreat Surg. 2017;21:194\u20138. https:\/\/doi.org\/10.14701\/ahbps.2017.21.4.194.","journal-title":"Ann Hepatobiliary Pancreat Surg."},{"key":"7062_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00259-021-05442-9","volume":"49","author":"F Ding","year":"2021","unstructured":"Ding F, Huang C, Liang C, Wang C, Liu J, Tang D. (68)Ga-FAPI-04 vs. (18)F-FDG in a longitudinal preclinical PET imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2021;49:290\u2013300. https:\/\/doi.org\/10.1007\/s00259-021-05442-9.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"7062_CR26","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.2967\/jnumed.121.263736","volume":"63","author":"A Pirasteh","year":"2022","unstructured":"Pirasteh A, Periyasamy S, Meudt JJ, Liu Y, Lee LM, Schachtschneider KM, et al. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model. J Nucl Med. 2022;63:1956\u201361. https:\/\/doi.org\/10.2967\/jnumed.121.263736.","journal-title":"J Nucl Med"},{"key":"7062_CR27","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/hep4.1850","volume":"6","author":"Q Chen","year":"2022","unstructured":"Chen Q, Chen AZ, Jia G, Li J, Zheng C, Chen K. Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma. Hepatol Commun. 2022;6:652\u201364. https:\/\/doi.org\/10.1002\/hep4.1850.","journal-title":"Hepatol Commun"},{"key":"7062_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2214\/AJR.12.8478","volume":"200","author":"NI Sainani","year":"2013","unstructured":"Sainani NI, Gervais DA, Mueller PR, Arellano RS. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1. Normal findings AJR Am J Roentgenol. 2013;200:184\u201393. https:\/\/doi.org\/10.2214\/AJR.12.8478.","journal-title":"Normal findings AJR Am J Roentgenol"},{"key":"7062_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00261-017-1281-6","volume":"43","author":"A Kielar","year":"2018","unstructured":"Kielar A, Fowler KJ, Lewis S, Yaghmai V, Miller FH, Yarmohammadi H, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018;43:218\u201330. https:\/\/doi.org\/10.1007\/s00261-017-1281-6.","journal-title":"Abdom Radiol (NY)"},{"key":"7062_CR30","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jmri.28659","volume":"57","author":"R Patel","year":"2023","unstructured":"Patel R, Aslam A, Parikh ND, Mervak B, Mubarak E, Higgins L, et al. Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI. J Magn Reson Imaging. 2023;57:1641\u201354. https:\/\/doi.org\/10.1002\/jmri.28659.","journal-title":"J Magn Reson Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-07062-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:26:26Z","timestamp":1745317586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-07062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7062"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-07062-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}